Beauty Farm Medical & Health Industry, Inc. (HK:2373)
:2373
Want to see HK:2373 full AI Analyst Report?
Top Page
Beauty Farm Medical & Health Industry, Inc.
(2373)
Select Model
Select Model
Rating:62Neutral
Price Target:
HK$21.50
▼(-18.44% Downside)
Action:Reiterated
Date:05/01/26
The score is driven primarily by solid financial performance (strong growth and improving margins) but is held back by higher leverage and some cash flow metric uncertainty. Technicals are a meaningful drag due to a sustained downtrend and negative momentum, while valuation is reasonable with a moderate P/E and a modest dividend yield.
Positive Factors
Revenue & margin expansion
A clear step-up in revenue alongside a rising net margin indicates the business is converting sales into profit more efficiently. This structural improvement suggests scalable demand, better pricing or cost control, and a stronger baseline for durable earnings and reinvestment over the next 2–6 months.
Negative Factors
Rising leverage
A sharp increase in leverage materially raises financial risk, limits strategic flexibility, and increases exposure to interest costs and refinancing risk. Higher debt levels can constrain capital allocation, reduce resilience to downturns, and elevate the chance of covenant or liquidity stress within months.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue & margin expansion
A clear step-up in revenue alongside a rising net margin indicates the business is converting sales into profit more efficiently. This structural improvement suggests scalable demand, better pricing or cost control, and a stronger baseline for durable earnings and reinvestment over the next 2–6 months.
Read all positive factors
Beauty Farm Medical & Health Industry, Inc. (2373) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$4.97B
Dividend Yield1.97%
Average Volume (3M)539.77K
Price to Earnings (P/E)17.8
Beta (1Y)0.42
Revenue Growth16.70%
EPS Growth38.98%
CountryHK
Employees5,609
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)1.38
Shares Outstanding251,593,720
10 Day Avg. Volume911,428
30 Day Avg. Volume539,766
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)5.54
Price to Sales (P/S)1.89
P/FCF Ratio6.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$31.31Price Target Upside18.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)1.8
Revenue Forecast (FY)HK$4.00B
Beauty Farm Medical & Health Industry, Inc. Business Overview & Revenue Model
Company Description
Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People's Republic of China It offers traditional beauty services; aesthetic medical services, including non-surgical aesthetic medical services, suc...
Beauty Farm Medical & Health Industry, Inc. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
56
Neutral
Cash Flow
62
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.00B | 2.57B | 2.15B | 1.64B | 1.78B |
| Gross Profit | 1.47B | 1.19B | 977.10M | 717.84M | 833.79M |
| EBITDA | 603.50M | 427.49M | 644.82M | 452.43M | 554.51M |
| Net Income | 317.56M | 228.46M | 215.66M | 103.11M | 193.47M |
Balance Sheet | |||||
| Total Assets | 5.05B | 4.28B | 3.30B | 2.50B | 2.48B |
| Cash, Cash Equivalents and Short-Term Investments | 2.57B | 1.83B | 1.57B | 910.63M | 1.08B |
| Total Debt | 1.29B | 730.59M | 563.12M | 525.50M | 515.46M |
| Total Liabilities | 3.98B | 3.30B | 2.47B | 2.29B | 2.21B |
| Stockholders Equity | 1.02B | 944.64M | 801.90M | 188.75M | 257.36M |
Cash Flow | |||||
| Free Cash Flow | 932.01M | 682.44M | 466.27M | 241.21M | 536.76M |
| Operating Cash Flow | 999.09M | 796.63M | 625.51M | 382.00M | 669.93M |
| Investing Cash Flow | -396.42M | -340.85M | -711.18M | 53.63M | -385.35M |
| Financing Cash Flow | 51.79M | -223.36M | 133.74M | -432.82M | -271.06M |
Beauty Farm Medical & Health Industry, Inc. Technical Analysis
Negative
26.36
Price Trends
20.47
Negative
23.23
Negative
27.15
Negative
Market Momentum
-0.38
Negative
46.53
Neutral
56.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2373, the sentiment is Negative. The current price of 26.36 is above the 20-day moving average (MA) of 20.04, above the 50-day MA of 20.47, and below the 200-day MA of 27.15, indicating a bearish trend. The MACD of -0.38 indicates Negative momentum. The RSI at 46.53 is Neutral, neither overbought nor oversold. The STOCH value of 56.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2373.
Beauty Farm Medical & Health Industry, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$6.35B | 17.47 | 15.36% | 2.61% | 7.60% | 20.01% | |
65 Neutral | HK$954.19M | 5.21 | 18.05% | 4.37% | -4.23% | 3.95% | |
62 Neutral | HK$4.97B | 17.83 | 33.08% | 1.97% | 16.70% | 38.98% | |
56 Neutral | HK$6.49B | 41.92 | 0.62% | ― | -9.81% | -72.56% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | HK$6.19B | 16.86 | -10.66% | 2.38% | -5.73% | -442.94% | |
49 Neutral | HK$77.43M | 41.14 | 1.67% | ― | -4.86% | ― |
* Healthcare Sector Average
HK:2373
Beauty Farm Medical & Health Industry, Inc.
20.28
1.29
6.79%
HK:1526
Rici Healthcare Holdings Ltd.
0.70
-0.39
-35.78%
HK:1951
Jinxin Fertility Group Ltd.
2.29
-0.49
-17.63%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.14
0.02
17.39%
HK:2273
Gushengtang Holdings Limited
26.64
-6.40
-19.37%
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
10.55
-4.49
-29.85%
Beauty Farm Medical & Health Industry, Inc. Corporate Events
Beauty Farm Boosts Profit and Dividend on Strong 2025 Growth in Premium Beauty Services
Mar 27, 2026
Beauty Farm Medical and Health Industry Inc., a major Chinese beauty and health service chain, focuses on one-stop beauty and wellness offerings for women in high-tier cities, leveraging a dual beauty plus dual wellness model. The company position...
Beauty Farm Medical and Health Industry Declares HKD 0.72 Final Dividend for 2025
Mar 27, 2026
Beauty Farm Medical and Health Industry Inc. has declared a final ordinary cash dividend of HKD 0.72 per share for the financial year ended 31 December 2025, subject to shareholder approval at a meeting scheduled for 26 June 2026. Key dates such a...
Beauty Farm Aggregates RMB280 Million in Principal-Guaranteed Wealth Products, Triggering Disclosure
Mar 20, 2026
Beauty Farm Medical and Health Industry Inc. has been channeling idle funds into principal-guaranteed wealth management products issued by SPD Bank through its subsidiaries Naturade Medical Instrument and Beijing Palaispa. The latest move on March...
Beauty Farm Sets March 27 Board Meeting and Earnings Call for 2025 Results
Mar 13, 2026
Beauty Farm Medical and Health Industry Inc. has scheduled a board meeting in Hong Kong on March 27, 2026 to review and approve its annual results for the year ended December 31, 2025 and to consider a potential final dividend proposal. Following ...
Beauty Farm Aggregates RMB240 Million in SPD Bank Wealth Products, Triggering Disclosure
Feb 13, 2026
Beauty Farm Medical and Health Industry Inc. has deployed idle funds into principal-guaranteed wealth management products issued by SPD Bank via its subsidiaries Beijing Palaispa and Shanghai Beauty Farm Medical and Health. The subscriptions, made...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.